World's Best Scientists 2026 revealed!

D-Index & Metrics

Economics and Finance

D-Index
33
Citations
4513
World Ranking
3289
National Ranking
118

Best Publications

  • Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis.

    Swathi Iyengar;Kiu Tay-Teo;Sabine Vogler;Peter Beyer

  • European collaborations on medicine and vaccine procurement.

    Sabine Vogler;Manuel A Haasis;Rianne van den Ham;Tifenn Humbert

  • Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study

    Sabine Vogler;Agnes Vitry;Zaheer Ud Din Babar

  • Introduction to drug utilization research

    Unknown

  • Pharmaceutical policies in European countries in response to the global financial crisis.

    Sabine Vogler;Nina Zimmermann;Christine Leopold;Kees de Joncheere

  • How can pricing and reimbursement policies improve affordable access to medicines? Lessons learned from European countries

    Sabine Vogler;Valérie Paris;Alessandra Ferrario;Veronika J. Wirtz

  • How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries

    Sabine Vogler;Valérie Paris;Alessandra Ferrario;Veronika J. Wirtz

  • Differences in external price referencing in Europe: a descriptive overview.

    Christine Leopold;Sabine Vogler;A.K. Mantel-Teeuwisse;Kees de Joncheere

  • Medication wasted – Contents and costs of medicines ending up in household garbage

    Unknown

  • Pharmaceutical regulation in 15 European countries review.

    Dimitra Panteli;Francis Arickx;Irina Cleemput;Guillaume Dedet

  • Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future

    Kim Pauwels;Isabelle Huys;Sabine Vogler;Minne Casteels

  • The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview

    Unknown

  • Payers' experiences with confidential pharmaceutical price discounts: A survey of public and statutory health systems in North America, Europe, and Australasia.

    Steven G. Morgan;Sabine Vogler;Anita K. Wagner

  • Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States

    Sabine Vogler;Claudia Habl;Martina Bogut;Luka Vončina

  • Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries

    Sabine Vogler;Katharina Habimana;Danielle Arts

  • Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure.

    Sabine Vogler;Peter Schneider;Martin Zuba;Reinhard Busse

  • Discounts and rebates granted to public payers for medicines in European countries.

    Unknown

  • The pharmaceutical distribution chain in the European Union: structure and impact on pharmaceutical prices

    Panos Kanavos;Willemien Schurer;Sabine Vogler

  • Medicines reimbursement policies in Europe

    Sabine Vogler;Manuel Alexander Haasis;Guillaume Dedet;Janice Lam

  • Strategies to achieve fairer prices for generic and biosimilar medicines

    Alessandra Ferrario;Guillaume Dedet;Tifenn Humbert;Sabine Vogler

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Recently Published Articles